As of September 2026, OMER's current EPS stands at $1.91, according to the latest financial reports. For the year 2025, the company recorded an earnings per share (EPS) of -$0.05, which marks an increase compared to its EPS of -$2.7 in 2024. OMER reported an EPS of $0.18 for the quarterly report ending on Jun 30, 2026.
For 2025, Omeros's EPS was -$0.05, an increase of 98.1% from -$2.7 in 2024. For the fiscal quarter that ended on Jun 30, 2026, the per-share earnings was $0.18, showing a 141.9% increase from the same quarter last year. For the twelve months ending June 2026, the EPS is $1.91. For the year 2024, the yearly earnings per share was -$2.7, marking a decrease of 43.6% from 2023.
During the last 12 months, Omeros has seen an EPS growth of 141.9% (YoY, quarterly).
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| OMER Omeros Corp | 9.29 | 98.1% | N/A | N/A |
| JNJ Johnson & Johnson | 30.69 | 90.6% | 17.7% | 14.8% |
| PFE Pfizer Inc | 36.24 | -3.5% | -37.4% | -3.7% |
All data is based on quarterly TTM periods, unless otherwise specified.